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The combination of public health benefits
and environmental risks associated with
DDT has made use of the pesticide contro-
versial (Walker et al. 2003). DDT was once
used extensively throughout the world, for
both agricultural and public health purposes
[Agency for Toxic Substances and Disease
Registry (ATSDR) 2002]. Use today is gener-
ally limited to vector control, primarily of
malaria, and is covered as of May 2004 by the
Stockholm Convention on Persistent Organic
Pollutants, a treaty signed by 151 countries
and currently ratiﬁed by more than 75 coun-
tries (Stockholm Convention on Persistent
Organic Pollutants 2004). Decisions in any
speciﬁc instance about whether to use DDT
even for vector control can be hotly debated
(Wendo 2004).
Use of DDT in the United States began
in the 1940s, peaked in the early 1960s, and
essentially ended in 1972. Timelines in other
countries differed but generally followed the
same pattern of steep rise and fall in amounts
used. Despite the decline in use, several com-
ponents and breakdown products of the
pesticide are still widely detectable in the
environment and in humans (Jaga and
Dharmani 2003; Smith 1999). The pesticide
product consists primarily of the actual insec-
ticide p,p´-DDT [1,1,1-trichloro-2,2-bis(p-
chlorophenyl)-ethane], with o,p´-DDT
[1,1,1-trichloro-2-(o-chlorophenyl)-2-(p-
chlorophenyl)-ethane] and several other
minor components making up the remainder
(ATSDR 2002). The primary degradation
product and human metabolite of p,p´-DDT
is p,p´-DDE [1,1-dichloro-2,2-bis(p-chloro-
phenyl)-ethylene]; the latter is also the most
persistent member of the DDT family and
the one that bioaccumulates most extensively
in humans.
The various components of the DDT fam-
ily have a number of known biologic actions.
The insecticidal effects of p,p´-DDT are attrib-
utable to neurotoxicity. A number of endo-
crine effects have been shown, including
antiandrogenic properties of p,p´-DDE (Gray
et al. 2001), estrogenic properties of o,p´-DDT
(Kupfer 1975), and modulation of steroid hor-
mone homeostasis through induction of
hepatic enzymes (Wyde et al. 2003; You et al.
2001). Changes in immune markers have been
seen (Vine et al. 2001). Carcinogenicity has
been demonstrated in animals, although evi-
dence in humans is mixed (Turusov et al.
2002). Associations with impaired lactation
have been reported (Gladen and Rogan 1995;
Rogan et al. 1987). Reproductive effects have
been shown as well. A large human study has
shown associations of maternal p,p´-DDE with
preterm birth and decreased birth weight
(Longnecker et al. 2001). Animal studies with
p,p´-DDE show a number of reproductive
abnormalities in male offspring (Gray et al.
2001); whether similar effects are seen in
humans at usual exposure levels is uncertain
(Flores-Luévano et al. 2003; Hosie et al. 2000;
Longnecker et al. 2002). Paternal occupational
DDT exposure has also been associated with
birth defects (Salazar-García et al. 2004).
Prenatal exposure to DDT can also have
delayed effects. There are reports of neurotoxic
and immunotoxic effects in young children
(Dewailly et al. 2000; Ribas-Fitó et al. 2003),
although not all studies show such effects
(Gladen et al. 1988; Rogan et al. 1987). At
even later ages, prenatal and lactational expo-
sure to p,p´-DDE in animals has been associ-
ated with delayed male puberty in some but
not all studies (Loeffler and Peterson 1999;
You et al. 1998).
A previous human study showed that ado-
lescent males with higher prenatal exposure to
p,p´-DDE had increases in both height and
body mass index (BMI) compared with those
with lower exposures; markers of puberty were
unaffected (Gladen et al. 2000). In view of the
continuing controversy about DDT and con-
cerns about substantial increases in childhood
obesity (Ogden et al. 2002), we examined
another population with higher exposures to
see whether similar effects in adolescent males
would be seen there.
Materials and Methods
Subjects. The Collaborative Perinatal Project
(CPP) was a large multicenter prospective
study of approximately 50,000 children born
between 1959 and 1966 (Broman 1984; Hardy
2003). Data collected included background
information on the mothers obtained from
questionnaires during pregnancy. Serum sam-
ples taken from the mothers during pregnancy
were stored, and many are still available.
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DDT (dichlorodiphenyltrichloroethane), a pesticide once used widely in agriculture and now limited
to public health use, remains a controversial chemical because of a combination of beneﬁts and risks.
DDT or its breakdown products are ubiquitous in the environment and in humans. Compounds in
the DDT family have endocrine actions and have been associated with reproductive toxicity. A previ-
ous study reported associations between prenatal exposure to p,p´-DDE [1,1-dichloro-2,2-bis(p-
chlorophenyl)-ethylene] and increased height and weight in adolescent boys. We examined a group
with higher exposures to see whether similar associations would occur. Our study group was
304 males born in Philadelphia in the early 1960s who had participated in a previous study.
Anthropometric and pubertal measures from one to six visits during their adolescent years were
available, as were stored maternal serum samples from pregnancy. We measured p,p´-DDE,
p,p´-DDT [1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane], and o,p´-DDT [1,1,1-trichloro-2-
(o-chlorophenyl)-2-(p-chlorophenyl)-ethane] in the maternal serum. Outcomes examined in the boys
were height, ratio of sitting height to height, body mass index, triceps skinfold thickness, ratio of
subscapular to the sum of triceps and subscapular skinfold thicknesses, skeletal age, serum testos-
terone, and serum dehydroepiandrosterone sulfate. No associations between prenatal exposure to any
of the DDT compounds and any outcome measure were seen. Key words: child development, DDE,
DDT, growth, prenatal exposure delayed effects, puberty. Environ Health Perspect 112:1761–1767
(2004). doi:10.1289/ehp.7287 available via http://dx.doi.org/ [Online 7 September 2004]
Children’s Health ArticleThe Philadelphia Blood Pressure Project
(PBPP) followed some of the children enrolled
at one of the CPP centers during adolescence
and early adulthood (Katz et al. 1980). This
was an urban population; the children had
been born at Pennsylvania Hospital and fol-
lowed at Children’s Hospital of Philadelphia.
Several subgroups were chosen for study;
one was a stratified random sample of those
enrolled in the CPP who were born between
1961 and 1965. These subjects were seen
annually up to three times in 1977–1980 and
again annually up to another three times in
1982–1985. Data collected included anthro-
pometric measurements and pubertal markers.
The subjects of the present study were cho-
sen from among the 373 singleton males from
the random sample studied in the PBPP. Of
those, 314 had stored maternal samples from
the third trimester available. Those samples were
shipped to the Centers for Disease Control and
Prevention and analyzed for several DDT com-
pounds. Of the samples shipped, nine had
insufﬁcient quantity for analysis, one was lost
during analysis, and 304 were successfully ana-
lyzed. The 304 boys whose maternal samples
were analyzed are the subjects of this report.
Primary variables. Anthropometric meas-
urements up to 20 years of age from the PBPP
were used; data from a total of 1,137 visits from
the 304 boys were available. Measurement tech-
niques and reliabilities have been discussed pre-
viously (Katz et al. 1980; Tanner et al. 1969).
Quantities measured at all visits included
height, sitting height, weight, triceps skinfold
thickness, and subscapular skinfold thickness.
Height and sitting height were measured using
a Holtain stadiometer (Holtain Ltd., Crymych,
Wales). Weight was measured on a Health-O-
Meter beam balance scale (Health-O-Meter,
Bridgeview, IL). Skinfolds were measured using
a Holtain skinfold caliper. We examined several
measures of overall size and body proportion:
height, the ratio of sitting height to height
(height ratio), BMI, triceps skinfold thickness,
and the ratio of subscapular to the sum of sub-
scapular and triceps skinfold thicknesses (a
measure of central adiposity). Missing data were
minimal: Height was unavailable four times,
sitting height 14 times, weight seven times, tri-
ceps skinfold thickness four times, and sub-
scapular skinfold thickness seven times.
Skeletal age was determined at the three
PBPP visits in 1977–1980, using the Tanner-
Whitehouse II method of rating hand–wrist
radiographs on the maturity of 20 individual
bones (Katz et al. 1980; Tanner et al. 1975).
Skeletal age was unavailable for 4% of the visits
where it was scheduled to be done.
Testosterone was measured at the first
two PBPP visits in 1977–1979 by radio-
immunoassay on samples of venous blood
collected at the time of examination
(Furuyama et al. 1970; Zemel and Katz 1986).
Dehydroepiandrosterone sulfate (DHEAS)
was measured only at the second visit in
1978–1979, again by radioimmunoassay
(Buster and Abraham 1972). Not all boys vol-
unteered for the blood draw; testosterone
was unavailable for 23% of the visits where it
was scheduled to be done, and DHEAS was
unavailable in 22%.
Maternal serum samples were analyzed for
p,p´-DDE, p,p´-DDT, and o,p´-DDT using a
semiautomated solid-phase extraction and gel
permeation chromatography cleanup followed
by an isotope dilution gas chromatography–
high resolution mass spectrometry analysis
(Barr et al. 2003; Sandau et al. 2003).
Recovery correction was done for each analyte
in each individual sample. For 25 samples,
p,p´-DDT could not be measured because of
quality control limit failure. Cholesterol and
triglycerides were also measured using standard
clinical assays. Total serum lipids were calcu-
lated as 62.3 + 2.27 cholesterol + triglycerides
(Phillips et al. 1989). Pesticide concentrations
were reported as nanograms of pesticide per
gram total serum lipids. The sum of the three
DDT compounds was calculated, unless
p,p´-DDT could not be measured. Samples
with nondetectable amounts for o,p´-DDT or
p,p´-DDT were considered to be zero; because
detection limits were low, imputing any other
value up to the detection limit changed the
sum of DDT by < 1% and never changed the
categories when exposure was categorized.
Statistical analysis. We used models to
examine outcome measurements in relation to
pesticide concentration after adjustment for
important predictors and potential con-
founders. The age of the boy at examination is
a key predictor and was included as a cubic
polynomial to allow for nonlinearity. Parental
size is also a strong predictor of child size;
maternal height and prepregnancy BMI were
available and were included as linear terms, but
paternal size was not available. We also adjusted
for breast-feeding (yes, no), maternal smoking
at the time of pregnancy (yes, no), number
of older siblings (0, 1, ≥ 2), race (African
American, white), maternal age at birth (13–19,
20–24, 25–29, ≥ 30 years), and maternal age at
menarche (8–11, 12, 13, ≥ 14 years). We used
the family socioeconomic index (SEI) score,
based on education, occupation, and income,
created by the CPP investigators for internal
comparisons (Myrianthopoulos and French
1968). Median SEI for the entire CPP was 4.3,
with a range from 0 to 9.5; scores here were cat-
egorized into three groups (0–2.5, 2.6–5.0,
≥ 5.1). A term for each boy was included as a
random effect to account for the correlation
among multiple measures of the same boy. For
triceps skinfold thickness and testosterone, the
analysis was done on a log scale. Tests of statis-
tical significance reported are either tests of
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Table 1. Background characteristics of boys and
their families.
Characteristic Percent
Race
White 15
African American 85
Maternal smoking at time of pregnancy
No 44
Yes 56
Breast-fed
Yes 6
No 94
No. of older siblings
02 5
12 5
≥ 25 0
Maternal height (cm)
144–155.9 29
156–165.9 54
166–181 17
Maternal prepregnancy BMI (kg/m2)
16–19.9 21
20–24.9 47
25–29.9 23
30–44 9
Maternal age at menarche (years)
8–11 21
12 29
13 25
≥ 14 26
Maternal age at enrollment in CPP (years)
13–19 23
20–24 36
25–29 23
30–42 18
Family SEI at time of pregnancy
0–2.5 17
2.6–5.0 59
≥ 5.1 24
Number of cases (of 304) with missing data: three for breast-
fed, one for number of older siblings, four for maternal
height, six for maternal prepregnancy BMI, two for maternal
age at menarche, 10 for family SEI at time of pregnancy.
Table 2. Distribution of chemical concentrations in
maternal serum.
Chemical Concentration (µg/g lipid) Percent
p,p´-DDE 1.0–2.9 14
3.0–5.9 38
6.0–8.9 24
9.0–11.9 13
12.0–25.1 11
p,p´-DDTa NDb–0.9 17
1.0–1.9 36
2.0–2.9 24
3.0–3.9 11
4.0–12.7 11
o,p´-DDT NDc–0.07 29
0.08–0.15 28
0.16–0.23 18
0.24–0.31 10
0.32–1.33 14
ΣDDTa 1.8–3.9 11
4.0–7.9 37
8.0–11.9 28
12.0–15.9 13
16.0–33.1 11
ND, not detected.
aNot available for 25 (of 304) boys because of quality control
limit failure. bOne sample had nondetectable p,p´-DDT
(detection limit, 0.01 µg/g lipid). cFifteen samples had non-
detectable o,p´-DDT (detection limits, 0.007–0.054 µg/g lipid).whether categories differ for discrete predictors
or tests for zero slope for continuous predictors.
Models were fit using SAS version 9 (SAS
Institute Inc., Cary, NC).
Results
Most of the 304 boys in this study were
African American (Table 1). Most of their
mothers reported smoking during pregnancy,
and few mothers breast-fed their sons. One-
quarter of the boys were ﬁrst-born. The distri-
bution of family SEI was similar to that of all
African Americans in the CPP. Other charac-
teristics of the mother and family around the
time of birth are shown in Table 1.
Concentrations of p,p´-DDE in maternal
serum during pregnancy ranged from 1 to
25 µg/g lipid (Table 2), with a median of 5.7
µg/g lipid. The other two DDT compounds
were present at lower concentrations; median
p,p´-DDT was 1.9 µg/g lipid, and median
o,p´-DDT was 0.14 µg/g lipid. The three
compounds measured were correlated; the
correlation of p,p´-DDE with p,p´-DDT was
0.65 and with o,p´-DDT was 0.58, whereas
p,p´-DDT and o,p´-DDT had a correlation
of 0.77.
The boys had from one to six adolescent
visits with anthropometric measurements avail-
able; 20% had one or two, 34% had three, and
47% had four or more. Age at the ﬁrst meas-
urement ranged from 10.8 to 17.9 years, with
a median of 12.8 years. Age at the last meas-
urement ranged from 12.2 to 20.0 years, with
a median of 17.6 years. Age at ﬁrst measure-
ment was a major determinant of number of
measurements, because those who were older
at the start of follow-up left the age range of
interest more quickly. In addition, no whites
had more than three visits.
Height ranged from 132 to 196 cm, with
the expected strong relationship to age. Selected
percentiles at each age are shown in Table 3.
Height ratio ranged from 46 to 55%. BMI
was skewed, ranging from 14 to 45 kg/m2.
Triceps skinfold was more skewed, ranging
from 3.5 to 43.4 mm. Central adiposity ranged
from 31 to 78%.
The boys also had up to three measures of
skeletal age; 66% had all three measurements,
and two boys had none. Skeletal age ranged
from 8.7 to 18 years. In addition, 260 boys
had one or two testosterone measurements
available, and 213 had a single measurement
of DHEAS. Testosterone ranged from 1 to
1,258 ng/dL; DHEAS ranged from 56 to
5,600 ng/mL.
The crude relationships of these anthro-
pometric and pubertal measures to maternal
prenatal concentrations of p,p´-DDE are
shown in Table 4 for several age ranges. Not
all boys had measurements available in all age
ranges; for skeletal ages and hormones, there
were few measurements past 17 years of age.
Little systematic relationship to p,p´-DDE
was seen for any of the measures.
Models as described above were ﬁt to these
measures to allow age to be treated as a contin-
uous predictor and to adjust for other predic-
tors and potential confounders (Table 5). In
no case was p,p´-DDE a statistically signiﬁcant
predictor of the outcome (all p > 0.10). Effects
of other predictors were seen. All outcomes
were signiﬁcantly related to the age of the boy
at measurement (data not shown). Height also
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Table 3. Percentiles of anthropometric and pubertal measures by age range (years).
Measure 10–10.9 11–11.9 12–12.9 13–13.9 14–14.9 15–15.9 16–16.9 17–17.9 18–18.9 19–20.0
Height (cm)
No. 10 97 149 185 140 111 105 118 111 107
90th — 157 165 171 177 180 184 185 185 185
Median 140 145 151 158 166 171 173 173 175 176
10th — 138 143 147 154 158 166 167 168 167
Height ratio (%)
No. 10 97 148 185 140 110 103 117 108 105
90th — 52.9 52.5 52.3 52.2 53.0 52.6 52.7 52.4 52.3
Median 52.0 51.1 50.5 50.3 50.1 50.2 50.5 50.8 50.8 50.8
10th — 49.4 49.0 48.8 48.7 48.3 48.4 49.0 49.1 49.4
BMI (kg/m2)
No. 10 97 149 185 139 111 105 118 110 106
90th — 22.0 23.9 23.7 24.2 25.2 24.6 27.5 27.5 27.8
Median 17.2 17.4 18.0 18.6 19.3 20.4 20.4 21.4 22.2 21.8
10th — 15.2 15.4 15.9 16.1 17.6 17.9 19.0 19.2 19.1
Triceps skinfold thickness (mm)
No. 10 97 149 185 140 111 105 118 111 107
90th — 16.9 18.2 16.7 16.1 17.1 10.3 15.0 15.3 14.6
Median 7.8 8.1 7.8 7.4 7.1 7.0 6.6 6.8 7.3 6.9
10th — 5.6 5.2 4.9 5.0 5.2 4.6 5.0 4.9 4.5
Central adiposity (%)
No. 9 97 148 185 140 110 105 118 111 107
90th — 52 54 56 56 58 60 63 64 65
median 44 46 47 48 49 52 55 56 56 58
10th — 40 41 41 42 42 46 49 49 50
Skeletal age (years)
No. 9 95 146 177 135 106 78 37 4 0
90th — 13.5 15.0 15.3 16.1 18.0 18.0 18.0 — —
Median 11.0 11.5 12.6 13.8 15.0 15.6 16.6 18.0 18.0 —
10th — 9.7 11.2 12.0 12.8 14.5 15.3 15.5 — —
Testosterone (ng/dL)
No. 4 66 104 76 69 59 32 5 0 0
90th — 160 336 430 517 575 787 — — —
Median 36 36 86 148 259 400 481 569 — —
10th — 13 21 38 44 110 327 — — —
DHEAS (ng/mL)
No. 0 4 67 43 32 31 30 6 0 0
90th — — 2,320 3,160 3,200 3,560 5,000 — — —
Median — 464 1,160 1,480 1,650 1,840 1,940 2,270 — —
10th — — 420 720 560 1,040 900 — — —
Values are number of measurements and percentiles; only the median is shown if n ≤ 10.increased with maternal height (p < 0.001) and
maternal BMI (p = 0.053); ﬁrst-born boys also
had higher means (p = 0.043), as did those
from families with higher SEI (p = 0.094).
Height ratio decreased with maternal height
(p < 0.001); whites also had larger means
(p < 0.001), as did later-born children
(p = 0.063) and those whose mothers had early
menarche (p = 0.095). BMI increased with
maternal BMI (p < 0.001). Triceps skinfold
increased with maternal BMI (p < 0.001); ﬁrst-
born boys (p = 0.037) and whites (p = 0.056)
had higher means. Mean central adiposity was
higher in African Americans (p = 0.002).
Testosterone was increased among those whose
mothers had early menarche (p = 0.052) and
those from families with higher SEI
(p = 0.092). Skeletal age and DHEAS showed
no signiﬁcant effects of predictors other than
age of the boy.
Use of p,p´-DDT, o,p´-DDT, or the sum
of the three compounds rather than p,p´-DDE
as the exposure also resulted in no signiﬁcant
effects on any of the outcomes analyzed (data
not shown). When the analysis shown in Table
5 was done separately for each of the age groups
used in Table 4, the results were again not sig-
niﬁcant with one exception. At the youngest
ages, the ﬁve exposure groups had signiﬁcantly
different BMIs, but the pattern was not monot-
onic in dose; as with the crude results in Table
4, the highest BMIs were seen for the 3–6 µg/g
dose group. If the analysis shown in Table 5 is
restricted to African Americans, the results are
essentially unchanged (data not shown).
Discussion
In this study, we found no association of pre-
natal exposure to p,p´-DDE, p,p´-DDT, or
o,p´-DDT with any of the anthropometric or
pubertal measures we examined in adolescent
males. In a previous study of 278 adolescent
boys and 316 girls, prenatal p,p´-DDE expo-
sure was also not related to pubertal markers
(Gladen et al. 2000). However, increased
exposure in that study was associated with
greater height and BMI of the boys. The sub-
jects of the present study, who were born dur-
ing the peak of DDT use in the United States,
had higher exposures than those in the previ-
ous study, who were born after agricultural
DDT use had been banned. Median
p,p´-DDE in maternal serum in the present
study was 5.7 µg/g serum lipid; the median in
the previous study was approximately equiva-
lent to 1.6 µg/g serum lipid [12.6 ng/g serum
(Rogan et al. 1986), converted assuming 8 g
lipid/L serum (Longnecker et al. 2003)]. The
failure to replicate the previous findings on
height and BMI in the present study with
higher exposures raises the possibility that the
earlier results may have been due to chance.
However, there were a number of differences
in the populations studied; for example, the
previous study subjects were mostly whites,
were mostly breast-fed, and had mothers who
were of higher socioeconomic status and less
likely to smoke.
Childhood concentration of p,p´-DDE has
also been studied in relation to childhood
height and pubertal development (Denham
et al. 2004; Karmaus et al. 2002), and adult
concentration of p,p´-DDE has been studied in
relation to testosterone and DHEAS (Ayotte et
al. 2001; Hagmar et al. 2001; Martin et al.
2002; Persky et al. 2001). However, these
studies have limited relevance to the question
addressed here. Prenatal exposure is likely to
act through different mechanisms than does
postnatal exposure. Childhood concentrations
of persistent organochlorines such as the DDT
compounds are poor surrogates for prenatal
exposures, because concentrations even into
adolescence are most strongly determined by
breast-feeding (Jacobson et al. 1989; Karmaus
et al. 2001; Nawrot et al. 2002).
The adolescent period studied here is a
time of rapid development, with changes in
body size and proportions, development of
secondary sexual characteristics, skeletal matu-
ration, and changes in the hormonal milieu all
occurring. Prenatal exposure to compounds
with endocrine activity might inﬂuence either
the timing or the ultimate result of any or all
of these changes. All of the outcome measures
we studied reflect some aspect of adolescent
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Table 4. Mean ± SE anthropometric and pubertal measures by maternal p,p´-DDE in speciﬁc age ranges (years).
p,p´-DDE (µg/g lipid) < 14 14–16.9 17–20
Height (cm)
< 3 151 ± 1.8 (28) 168 ± 1.9 (26) 174 ± 1.5 (25)
3–5.9 154 ± 0.9 (76) 168 ± 0.9 (86) 176 ± 0.8 (67)
6–8.9 155 ± 1.2 (50) 170 ± 1.3 (50) 176 ± 1.0 (51)
9–11.9 157 ± 2.0 (27) 173 ± 1.7 (24) 177 ± 1.5 (24)
≥ 12 152 ± 1.9 (18) 168 ± 2.1 (21) 173 ± 1.4 (19)
Height ratio (%)
< 3 50.8 ± 0.3 (28) 51.1 ± 0.4 (26) 51.2 ± 0.3 (25)
3–5.9 50.8 ± 0.1 (76) 50.6 ± 0.2 (84) 51.0 ± 0.2 (66)
6–8.9 50.7 ± 0.2 (50) 50.3 ± 0.2 (50) 50.7 ± 0.2 (51)
9–11.9 50.2 ± 0.3 (27) 50.3 ± 0.3 (24) 50.3 ± 0.3 (24)
≥ 12 50.7 ± 0.3 (18) 50.2 ± 0.3 (21) 50.9 ± 0.4 (18)
BMI (kg/m2)
< 3 17.9 ± 0.5 (28) 21.6 ± 1.0 (26) 21.5 ± 0.6 (25)
3–5.9 20.0 ± 0.5 (76) 20.8 ± 0.5 (85) 22.9 ± 0.4 (67)
6–8.9 18.9 ± 0.4 (50) 20.4 ± 0.5 (50) 22.6 ± 0.4 (51)
9–11.9 18.3 ± 0.5 (27) 21.3 ± 1.0 (24) 22.3 ± 0.9 (24)
≥ 12 18.2 ± 0.5 (18) 19.7 ± 0.6 (21) 21.2 ± 0.6 (19)
Triceps skinfold thickness (mm)
< 3 8.5 ± 0.6 (28) 10.3 ± 1.5 (26) 7.5 ± 0.6 (25)
3–5.9 11.0 ± 0.8 (76) 8.4 ± 0.5 (86) 8.9 ± 0.6 (67)
6–8.9 9.4 ± 0.7 (50) 8.5 ± 0.7 (50) 8.7 ± 0.6 (51)
9–11.9 8.9 ± 0.9 (27) 9.1 ± 1.5 (24) 8.6 ± 1.4 (24)
≥ 12 8.1 ± 0.7 (18) 8.2 ± 0.8 (21) 7.2 ± 0.8 (19)
Central adiposity (%)
< 3 46.2 ± 0.8 (28) 49.1 ± 1.0 (26) 56.8 ± 0.9 (25)
3–5.9 47.6 ± 0.6 (75) 51.9 ± 0.6 (86) 56.1 ± 0.6 (67)
6–8.9 47.7 ± 0.7 (50) 51.2 ± 0.7 (50) 55.3 ± 0.8 (51)
9–11.9 48.0 ± 0.7 (27) 50.8 ± 1.0 (24) 58.1 ± 0.9 (24)
≥ 12 46.5 ± 1.1 (18) 50.7 ± 1.0 (21) 57.2 ± 1.3 (19)
Skeletal age (years)
< 3 12.4 ± 0.3 (28) 15.8 ± 0.3 (24)
3–5.9 13.1 ± 0.1 (72) 15.4 ± 0.1 (73)
6–8.9 13.0 ± 0.2 (50) 15.4 ± 0.2 (43)
9–11.9 13.1 ± 0.3 (27) 15.9 ± 0.2 (22)
≥ 12 13.0 ± 0.3 (18) 15.6 ± 0.3 (21)
Testosterone (ng/dL)
< 3 124 ± 26 (26) 376 ± 33 (18)
3–5.9 136 ± 17 (63) 321 ± 28 (43)
6–8.9 172 ± 25 (42) 346 ± 46 (25)
9–11.9 111 ± 19 (24) 491 ± 103 (11)
≥ 12 142 ± 41 (13) 333 ± 52 (15)
DHEAS (ng/mL)
< 3 1,355 ± 184 (20) 2,248 ± 274 (16)
3–5.9 1,431 ± 142 (40) 1,901 ± 168 (35)
6–8.9 1,428 ± 186 (28) 1,911 ± 218 (19)
9–11.9 1,236 ± 186 (18) 2,352 ± 476 (10)
≥ 12 1,240 ± 180 (8) 2,186 ± 492 (13)
For each boy, all available measurements in the speciﬁed age range are averaged. Values are mean ± SE of these aver-
ages (no. of boys). Skeletal age and hormone concentrations are not shown in the upper age range because they were
available for few boys.development, although we do lack some clas-
sic outcomes such as Tanner stages and time
of peak height velocity. Height increases with
age, although it levels off in the later teens;
height ratio first declines and then increases
with age as body proportions shift (Hamill
et al. 1973; Malina et al. 1974). BMI increases
with age, albeit with considerable variability.
Triceps skinfold thickness declines with age,
again with considerable variability; it also
becomes smaller relative to subscapular skin-
fold thickness, such that central adiposity
increases. Skeletal age increases with chrono-
logical age, up to full maturity at skeletal age
18. Testosterone and DHEAS concentrations
increase with age, with considerable variabil-
ity. The substantial variability seen with some
of these measures means that our failure to
find associations of prenatal exposure to the
DDT compounds with any of these outcomes
could be due to inadequate power, although
the patterns of the observed relationships do
not suggest this explanation.
We did have adequate power to discern
effects of other known predictors. As expected,
height and BMI of boys were inﬂuenced by the
height and BMI of their mothers, consistent
with previous work (Celi et al. 2003; Wingerd
and Schoen 1974). The racial differences we
saw were consistent with those seen elsewhere.
In a national survey, the relationship of height
and weight to race was inconsistent across
age, but height ratio showed a clear racial differ-
ence (Hamill et al. 1973). In the same survey,
whites had greater triceps skinfolds than did
African Americans but similar subscapular
skinfolds, leading to lower central adiposity
(Johnston et al. 1974); racial differences in
skeletal age were inconsistent across ages (Roche
et al. 1975, 1978). First-born children have
been shown to be taller and heavier (Celi et al.
2003; Ong et al. 2002; Wingerd and Schoen
1974), consistent with our ﬁndings; increased
skinfold thickness among ﬁrst-borns has also
been reported in another investigation based
on the PBPP (Stettler et al. 2000). Prenatal
exposure to smoking has been associated with
decreased height (Fogelman 1980) and
increased obesity (Power and Jefferis 2002); our
results were in the expected direction, although
they did not achieve statistical signiﬁcance. Our
sample included very few breast-fed children,
consistent with the low overall breast-feeding
rates at that time and with the lower rates
in African Americans and in the Northeast
(Hirschman and Hendershot 1979), so the fail-
ure to see any associations of our outcomes to
breast-feeding was not surprising.
Although there are many early inﬂuences
on later development, such as the association of
prenatal exposure to certain antipsychotic drugs
with later height (Platt et al. 1988), most would
be expected to be unrelated to exposure to
DDT and thus are not candidate confounders.
We controlled for the most likely confounders,
although observational studies are always sub-
ject to potential residual confounding. We had
no information about maternal diet before
pregnancy or about the diet of the child after
birth; maternal diet is a predictor of the expo-
sure, and childhood diet is a predictor of
growth and development. Adjusting for pater-
nal size might have made our estimates more
precise, but this information was not available.
Birth weight has been shown to be related to
prenatal p,p´-DDE exposure in the CPP popu-
lation (Longnecker et al. 2001); however, we
did not consider it appropriate to adjust for
birth weight because this is an intermediate
variable in the relationships between exposure
and adolescent outcomes.
Children’s Health | Prenatal DDT and anthropometry and puberty in boys
Environmental Health Perspectives • VOLUME 112 | NUMBER 17 | December 2004 1765
Table 5. Regression of anthropometric and pubertal measures on maternal p,p´-DDE and other predictors.
Height Height BMI Triceps Central Skeletal Testosterone DHEAS
Predictor, category/units (cm) ratio (%) (kg/m2) (log mm) adiposity (%) age (years) (log ng/dL) (ng/mL)
Maternal p,p´-DDE (µg/g lipid)
< 3 0 (ref) 0 (ref) 0 (ref) 0 (ref) 0 (ref) 0 (ref) 0 (ref) 0 (ref)
3–5.9 1.1 ± 1.3 0.1 ± 0.2 0.9 ± 0.7 0.06 ± 0.08 1.1 ± 0.9 0.4 ± 0.2 0.0 ± 0.2 –158 ± 217
6–8.9 1.0 ± 1.5 0.1 ± 0.2 0.2 ± 0.8 0.00 ± 0.09 0.5 ± 1.0 0.3 ± 0.3 0.1 ± 0.2 –140 ± 252
9–11.9 2.2 ± 1.7 0.0 ± 0.3 0.6 ± 0.9 0.00 ± 0.10 1.7 ± 1.2 0.5 ± 0.3 0.0 ± 0.2 –109 ± 281
≥ 12 0.4 ± 1.8 0.0 ± 0.3 –0.4 ± 0.9 –0.01 ± 0.11 0.6 ± 1.2 0.2 ± 0.3 0.1 ± 0.2 –148 ± 307
Maternal height per 10 cm 4.4 ± 0.7** –0.5 ± 0.1** –0.2 ± 0.4 0.05 ± 0.04 0.0 ± 0.5 –0.1 ± 0.1 -0.1 ± 0.1 –32 ± 114
Maternal BMI per 10 kg/m2 2.0 ± 1.0* 0.0 ± 0.2 2.2 ± 0.5** 0.25 ± 0.06** -0.3 ± 0.7 0.2 ± 0.2 0.2 ± 0.1 280 ± 179
Race
White -0.9 ± 1.3 2.1 ± 0.2 0.4 ± 0.7 0.15 ± 0.08 –2.8 ± 0.9 0.0 ± 0.2 0.0 ± 0.2 –110 ± 227
African American 0 (ref) 0 (ref)** 0 (ref) 0 (ref)* 0 (ref)** 0 (ref) 0 (ref) 0 (ref)
No. of older siblings
0 0 (ref)** 0 (ref)* 0 (ref) 0 (ref)** 0 (ref) 0 (ref) 0 (ref) 0 (ref)
1 –1.1 ± 1.3 0.0 ± 0.2 –0.6 ± 0.7 –0.11 ± 0.08 1.4 ± 0.9 –0.3 ± 0.2 –0.2 ± 0.2 –320 ± 235
≥ 2 –3.2 ± 1.4 0.4 ± 0.2 –0.9 ± 0.7 –0.21 ± 0.08 1.7 ± 0.9 –0.5 ± 0.2 –0.2 ± 0.2 –522 ± 245
Maternal smoking in pregnancy
No 0 (ref) 0 (ref) 0 (ref) 0 (ref) 0 (ref) 0 (ref) 0 (ref) 0 (ref)
Yes –0.2 ± 0.8 –0.2 ± 0.1 0.3 ± 0.5 0.02 ± 0.05 0.7 ± 0.6 0.0 ± 0.1 0.0 ± 0.1 60 ± 152
Breast-fed
No 0.4 ± 1.7 –0.3 ± 0.3 0.5 ± 0.9 0.12 ± 0.10 –0.7 ± 1.2 -0.1 ± 0.3 0.1 ± 0.2 –247 ± 285
Yes 0 (ref) 0 (ref) 0 (ref) 0 (ref) 0 (ref) 0 (ref) 0 (ref) 0 (ref)
Family SEI
≥ 5.1 2.4 ± 1.4 0.4 ± 0.2 1.1 ± 0.7 0.12 ± 0.08 –0.3 ± 0.9 0.4 ± 0.2 0.4 ± 0.2 207 ± 238
2.6–5.0 2.5 ± 1.2 0.1 ± 0.2 0.7 ± 0.6 0.04 ± 0.07 0.0 ± 0.8 0.4 ± 0.2 0.2 ± 0.2 184 ± 204
0–2.5 0 (ref)* 0 (ref) 0 (ref) 0 (ref) 0 (ref) 0 (ref) 0 (ref)* 0 (ref)
Maternal age at enrollment (years)
13–19 –0.9 ± 1.8 –0.1 ± 0.3 –0.7 ± 1.0 –0.20 ± 0.11 1.7 ± 1.2 –0.4 ± 0.3 0.2 ± 0.2 –340 ± 318
20–24 –0.6 ± 1.3 –0.3 ± 0.2 –0.5 ± 0.7 –0.08 ± 0.08 0.4 ± 0.9 –0.2 ± 0.2 –0.1 ± 0.2 –122 ± 237
25–29 0.2 ± 1.4 –0.4 ± 0.2 0.2 ± 0.7 –0.05 ± 0.08 0.5 ± 1.0 0.0 ± 0.2 0.2 ± 0.2 –252 ± 243
≥ 30 0 (ref) 0 (ref) 0 (ref) 0 (ref) 0 (ref) 0 (ref) 0 (ref) 0 (ref)
Maternal age at menarche (years)
8–11 0 (ref) 0 (ref)* 0 (ref) 0 (ref) 0 (ref) 0 (ref) 0 (ref)* 0 (ref)
12 –0.6 ± 1.2 –0.5 ± 0.2 0.0 ± 0.6 0.03 ± 0.07 –1.2 ± 0.8 –0.3 ± 0.2 –0.5 ± 0.2 –77 ± 212
13 0.3 ± 1.3 –0.4 ± 0.2 –0.4 ± 0.7 0.00 ± 0.08 –0.9 ± 0.9 –0.2 ± 0.2 –0.3 ± 0.2 47 ± 228
≥ 14 1.0 ± 1.3 –0.4 ± 0.2 –0.3 ± 0.7 0.00 ± 0.08 –1.3 ± 0.9 –0.4 ± 0.2 –0.3 ± 0.2 –52 ± 223
ref, reference. Values are regression coefﬁcients ± SE, adjusted for all others shown and also for age of boy at measurement and correlation among multiple measures of the same boy.
*p < 0.10, **p < 0.05, for tests of whether discrete groups differ or continuous slope is nonzero.We measured exposure using third-
trimester serum samples. Specific aspects of
prenatal development occur during critical
windows, so timing of exposure can be impor-
tant. However, for persistent compounds
such as DDT, concentrations are generally sta-
ble over periods of months or longer, with
little variation over the course of pregnancy
(Longnecker et al. 1999). The analytical meth-
ods used were sensitive, selective, and reliable,
with relative standard deviations, including
both the error from the sample preparation
and the instrumental methods, of 11% and
detection limits in the low picograms per
millilliter range (Barr et al. 2003).
The participants in the study were not a
random sample of the general population.
Those enrolled in the CPP from the Phila-
delphia study center were clinic patients who
were planning to deliver at the study hospital
(Broman 1984); they were mostly African
American and relatively low income, repre-
sentative of the population obtaining medical
care at this clinic. The PBPP study group was
a random sample of the CPP study group
(Katz et al. 1980). We have no information
about exposure among those who chose not
to participate in either the base CPP study or
the PBPP follow-up, but there is no reason to
anticipate that prenatal DDT exposure would
differ between participants and nonpartici-
pants. Refusal rates were greatest for the hor-
mone measurements, but there was little
systematic relationship to exposure; for exam-
ple, among African Americans, those with
both testosterone measurements available had
a median p,p´-DDE of 6.2, whereas those
with none or one, due to either a missed visit
or a refusal, had a median of 6.3.
In summary, we have seen no association
between prenatal exposure to DDT-related
compounds and several anthropometric and
pubertal measures in males. However, high
variability in some of the outcome measures
means we cannot rule out subtle changes.
REFERENCES
ATSDR. 2002. Toxicological Profile for DDT, DDE, and DDD.
Atlanta, GA:Agency for Toxic Substances and Disease
Registry.
Ayotte P, Giroux S, Dewailly É, Hernández Avila M, Farias P,
Danis R, et al. 2001. DDT spraying for malaria control and
reproductive function in Mexican men. Epidemiology
12:366–367.
Barr JR, Maggio VL, Barr DB, Turner WE, Sjödin A, Sandau CD,
et al. 2003. New high-resolution mass spectrometric approach
for the measurement of polychlorinated biphenyls and
organochlorine pesticides in human serum. J Chromatogr B
Analyt Technol Biomed Life Sci 794:137–148.
Broman S. 1984. The Collaborative Perinatal Project: an
overview. In: Handbook of Longitudinal Research (Medrick
SA, Harway M, Finello KM, eds). New York:Praeger
Publications, 185–215.
Buster JE, Abraham GE. 1972. Radioimmunoassay of plasma
dehydroepiandrosterone sulfate. Anal Lett 5:543–551.
Celi F, Bini V, DeGiorgi G, Molinari D, Faraoni F, DiStefano G,
et al. 2003. Epidemiology of overweight and obesity among
school children and adolescents in three provinces of
central Italy, 1993–2001: study of potential inﬂuencing vari-
ables. Eur J Clin Nutr 57:1045–1051.
Denham M, Deane G, Gallo MV, Ravenscroft J, Decaprio A,
Schell L. 2004. Age at menarche among Akwesasne
Mohawk girls exposed to lead, mercury, mirex, dichloro-
diphenyldichloroethane (DDE), hexachlorobenzene (HCB)
and polychlorinated biphenyls (PCBs) [Abstract]. Am J
Hum Biol 16:201.
Dewailly É, Ayotte P, Bruneau S, Gingras S, Belles-Isles M, Roy R.
2000. Susceptibility to infections and immune status in Inuit
infants exposed to organochlorines. Environ Health Perspect
108:205–211.
Flores-Luévano S, Farías P, Hernández M, Romano-Riquer P,
Weber JP, Dewailly E, et al. 2003. Concentraciones de
DDT/DDE y riesgo de hipospadias. Un estudio piloto de casos
y controles [in Spanish]. Salud Publica Mex 45:431–438.
Fogelman K. 1980. Smoking in pregnancy and subsequent
development of the child. Child Care Health Dev 6:233–249.
Furuyama S, Mayes DM, Nugent CA. 1970. A radioimmuno-
assay for plasma testosterone. Steroids 16:415–428.
Gladen BC, Ragan NB, Rogan WJ. 2000. Pubertal growth and
development and prenatal and lactational exposure to
PCBs and DDE. J Pediatr 136:490–496.
Gladen BC, Rogan WJ. 1995. DDE and shortened duration of
lactation in a northern Mexican town. Am J Public Health
85:504–508.
Gladen BC, Rogan WJ, Hardy P, Thullen J, Tingelstad J, Tully M.
1988. Development after exposure to polychlorinated
biphenyls and dichlorodiphenyl dichloroethene transpla-
centally and through human milk. J Pediatr 113:991–995.
Gray LE, Ostby J, Furr J, Wolf CJ, Lambright C, Parks L, et al.
2001. Effects of environmental antiandrogens on reproduc-
tive development in experimental animals. Hum Reprod
Update 7:248–264.
Hagmar L, Björk J, Sjödin A, Bergman Å, Erfurth EM. 2001. Plasma
levels of persistent organohalogens and hormone levels in
adult male humans. Arch Environ Health 56:138–143.
Hamill PVV, Johnston FE, Lemeshow S. 1973. Body weight,
stature, and sitting height: white and Negro youths 12–17
years: United States. Vital Health Stat 11 126:1–40.
Hardy JB. 2003. The Collaborative Perinatal Project: lessons
and legacy. Ann Epidemiol 13:303–311.
Hirschman C, Hendershot GE. 1979. Trends in breast feeding
among American mothers. Vital Health Stat 23 3:1–46.
Hosie S, Loff S, Witt K, Niessen K, Waag KL. 2000. Is there a
correlation between organochlorine compounds and
undescended testes? Eur J Pediatr Surg 10:304–309.
Jacobson JL, Humphrey HEB, Jacobson SW, Schantz SL,
Mullin MD, Welch R. 1989. Determinants of polychlori-
nated biphenyls (PCBs), polybrominated biphenyls (PBBs),
and dichlorodiphenyl trichloroethane (DDT) levels in the
sera of young children. Am J Public Health 79:1401–1404.
Jaga K, Dharmani C. 2003. Global surveillance of DDT and DDE
levels in human tissues. Int J Occup Med Environ Health
16:7–20.
Johnston EE, Hamill PVV, Lemeshow S. 1974. Skinfold thickness
of youths 12–17 years, United States. Vital Health Stat 11
132:1–75.
Karmaus W, Asakevich S, Indurkhya A, Witten J, Kruse H. 2002.
Childhood growth and exposure to dichlorodiphenyl
dichloroethene and polychlorinated biphenyls. J Pediatr
140:33–39.
Karmaus W, DeKoning EP, Kruse H, Witten J, Osius N. 2001.
Early childhood determinants of organochlorine concen-
trations in school-aged children. Pediatr Res 50:331–336.
Katz SH, Hediger ML, Schall JI, Bowers EJ, Barker WF, Aurand S,
et al. 1980. Blood pressure, growth and maturation from
childhood through adolescence: mixed longitudinal analyses
of the Philadelphia Blood Pressure Project. Hypertension
2:I55–I69.
Kupfer D. 1975. Effects of pesticides and related compounds on
steroid metabolism and function. Crit Rev Toxicol 4:83–124.
Loefﬂer IK, Peterson RE. 1999. Interactive effects of TCDD and
p,p’-DDE on male reproductive tract development in in utero
and lactationally exposed rats. Toxicol Appl Pharmacol
154:28–39.
Longnecker MP, Klebanoff MA, Brock JW, Zhou H, Gray KA,
Needham LL, et al. 2002. Maternal serum level of 1,1-
dichloro-2,2-bis(p-chlorophenyl)ethylene and risk of cryp-
torchidism, hypospadias, and polythelia among male
offspring. Am J Epidemiol 155:313–322.
Longnecker MP, Klebanoff MA, Gladen BC, Berendes HW. 1999.
Serial levels of serum organochlorines during pregnancy
and postpartum. Arch Environ Health 54:110–114.
Longnecker MP, Klebanoff MA, Zhou H, Brock JW. 2001.
Association between maternal serum concentration of the
DDT metabolite DDE and preterm and small-for-gesta-
tional-age babies at birth. Lancet 358:110–114.
Longnecker MP, Wolff MS, Gladen BC, Brock JW, Grandjean P,
Jacobson JL, et al. 2003. Comparison of polychlorinated
biphenyl levels across studies of human neurodevelopment.
Environ Health Perspect 111:65–70.
Malina RM, Hamill PVV, Lemeshow S. 1974. Body dimensions
and proportions, white and Negro children, 6–11 years,
United States. Vital Health Stat 11 143:1–71.
Martin SA Jr, Harlow SD, Sowers MF, Longnecker MP,
Garabrant D, Shore DL, et al. 2002. DDT metabolite and
androgens in African-American farmers. Epidemiology
13:454–458.
Myrianthopoulos NC, French KS. 1968. An application of the
U.S. Bureau of the Census socioeconomic index to a large,
diversiﬁed patient population. Soc Sci Med 2:283–299.
Nawrot TS, Staessen JA, Den Hond EM, Koppen G, Schoeters G,
Fagard R, et al. 2002. Host and environmental determinants
of polychlorinated aromatic hydrocarbons in serum of ado-
lescents. Environ Health Perspect 110:583–589.
Ogden CL, Flegal KM, Carroll MD, Johnson CL. 2002. Prevalence
and trends in overweight among US children and adoles-
cents, 1999–2000. JAMA 288:1728–1732.
Ong KKL, Preece MA, Emmett PM, Ahmed ML, Dunger DB,
ALSPAC Study Team. 2002. Size at birth and early childhood
growth in relation to maternal smoking, parity and infant
breast-feeding: longitudinal birth cohort study and analysis.
Pediatr Res 52:863–867.
Persky V, Turyk M, Anderson HA, Hanrahan LP, Falk C,
Steenport DN, et al. 2001. The effects of PCB exposure and
fish consumption on endogenous hormones. Environ
Health Perspect 109:1275–1283.
Phillips DL, Pirkle JL, Burse VW, Bernert JT Jr, Henderson LO,
Needham LL. 1989. Chlorinated hydrocarbon levels in
human serum: effects of fasting and feeding. Arch Environ
Contam Toxicol 18:495–500.
Platt JE, Friedhoff AJ, Broman SH, Bond RN, Laska E, Lin SP.
1988. Effects of prenatal exposure to neuroleptic drugs on
children’s growth. Neuropsychopharmacology 1:205–212.
Power C, Jefferis BJ. 2002. Fetal environment and subsequent
obesity: a study of maternal smoking. Int J Epidemiol
31:413–419.
Ribas-Fitó N, Cardo E, Sala M, de Muga ME, Mazón C, Verdú A,
et al. 2003. Breastfeeding, exposure to organochlorine
compounds, and neurodevelopment in infants. Pediatrics
111:e580–e585.
Roche AF, Roberts J, Hamill PVV. 1975. Skeletal maturity of
children 6–11 years: racial, geographic area, and socio-
economic differentials: United States. Vital Health Stat 11
149:1–88.
Roche AF, Roberts J, Hamill PVV. 1978. Skeletal maturity of
youths 12–17 years: racial, geographic area, and socio-
economic differentials: United States, 1966–1970. Vital
Health Stat 11 167:1–107.
Rogan WJ, Gladen BC, McKinney JD, Carreras N, Hardy P,
Thullen J, et al. 1986. Polychlorinated biphenyls (PCBs)
and dichlorodiphenyl dichloroethene (DDE) in human milk:
effects of maternal factors and previous lactation. Am J
Public Health 76:172–177.
Rogan WJ, Gladen BC, McKinney JD, Carreras N, Hardy P,
Thullen J, et al. 1987. Polychlorinated biphenyls (PCBs)
and dichlorodiphenyl dichloroethene (DDE) in human milk:
effects on growth, morbidity, and duration of lactation. Am
J Public Health 77:1294–1297.
Salazar-García F, Gallardo-Díaz E, Cerón-Mireles P, Loomis D,
Borja-Aburto VH. 2004. Reproductive effects of occupa-
tional DDT exposure among male malaria control workers.
Environ Health Perspect 112:542–547.
Sandau CD, Sjödin A, Davis MD, Barr JR, Maggio VL,
Waterman AL, et al. 2003. Comprehensive solid-phase
extraction method for persistent organic pollutants.
Validation and application to the analysis of persistent
chlorinated pesticides. Anal Chem 75:71–77.
Smith D. 1999. Worldwide trends in DDT levels in human breast
milk. Int J Epidemiol 28:179–188.
Stettler N, Tershakovec AM, Zemel BS, Leonard MB, Boston RC,
Katz SH, et al. 2000. Early risk factors for increased adipos-
ity: a cohort study of African American subjects followed
from birth to young adulthood. Am J Clin Nutr 72:378–383.
Stockholm Convention on Persistent Organic Pollutants. 2004.
Stockholm Convention on Persistent Organic Pollutants
(POPs). Geneva:Secretariat for the Stockholm Convention
Children’s Health | Gladen et al.
1766 VOLUME 112 | NUMBER 17 | December 2004 • Environmental Health Perspectiveson Persistent Organic Pollutants. Available: http://www.
pops.int [accessed 24 August 2004].
Tanner JM, Hiernaux J, Jarman S. 1969. Growth and physique
studies. In: Human Biology, A Guide to Field Methods
(Weiner JS, Lourie JA, eds). IBP Handbook No. 9.
Oxford:Blackwell, International Biological Programme, 2–71.
Tanner JM, Whitehouse RH, Marshall WA, Healy MJR,
Goldstein H. 1975. Assessment of Skeletal Maturity and
Prediction of Adult Height (Tanner-Whitehouse II Method).
London:Academic Press.
Turusov V, Rakitsky V, Tomatis L. 2002. Dichlorodiphenyltrichloro-
ethane (DDT): ubiquity, persistence, and risks. Environ
Health Perspect 110:125–128.
Vine MF, Stein L, Weigle K, Schroeder J, Degnan D, Tse CK,
et al. 2001. Plasma 1,1-dichloro-2,2-bis(p-chlorophenyl)ethyl-
ene (DDE) levels and immune response. Am J Epidemiol
153:53–63.
Walker KR, Ricciardone MD, Jensen J. 2003. Developing an
international consensus on DDT: a balance of environmen-
tal protection and disease control. Int J Hyg Environ Health
206:423–435.
Wendo C. 2004. Uganda considers DDT to protect homes from
malaria. Health officials claim DDT will help save money,
but critics warn of environmental costs. Lancet 363:1376.
Wingerd J, Schoen EJ. 1974. Factors inﬂuencing length at birth
and height at ﬁve years. Pediatrics 53:737–741.
Wyde ME, Bartolucci E, Ueda A, Zhang H, Yan B, Negishi M, et al.
2003. The environmental pollutant 1,1-dichloro-2,2-bis
(p-chlorophenyl)ethylene induces rat hepatic cytochrome
P450 2B and 3A expression through the constitutive
androstane receptor and pregnane X receptor. Mol
Pharmacol 64:474–481.
You L, Casanova M, Archibeque-Engle S, Sar M, Fan LQ, Heck HD.
1998. Impaired male sexual development in perinatal
Sprague-Dawley and Long-Evans Hooded rats exposed
in utero and lactationally to p,p´-DDE. Toxicol Sci 45:162–173.
You L, Sar M, Bartolucci E, Ploch S, Whitt M. 2001. Induction of
hepatic aromatase by p,p´-DDE in adult male rats. Mol Cell
Endocrinol 178:207–214.
Zemel BS, Katz SH. 1986. The contribution of adrenal and
gonadal androgens to the growth in height of adolescent
males. Am J Phys Anthropol 71:459–466.
Children’s Health | Prenatal DDT and anthropometry and puberty in boys
Environmental Health Perspectives • VOLUME 112 | NUMBER 17 | December 2004 1767